The evolving challenge of chronic heart failure management A call for a new curriculum for training heart failure specialists by Adamson, Philip B. et al.
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he Evolving Challenge
f Chronic Heart Failure Management
Call for a New Curriculum for Training Heart Failure Specialists
hilip B. Adamson, MD, FACC,* William T. Abraham, MD, FACC,† Charles Love, MD, FACC,†
wight Reynolds, MD, FACC*
klahoma City, Oklahoma; and Columbus, Ohio
Chronic heart failure (HF) is a growing epidemic, and therapy options are becoming more
complex. Specifically, device management of HF represents a new “class” of therapy that can
reduce mortality and alleviate morbidity of the disease syndrome. Heart failure training
programs seldom provide structured opportunities for trainees to gain competence in device
implantation and management. This curriculum outlines a new approach to training
interventional HF cardiologists and internal medicine HF specialists to meet the growing
demands for specially trained health care providers. (J Am Coll Cardiol 2004;44:1354–7)
© 2004 by the American College of Cardiology Foundationi
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mver the last 30 years, an evidence base that furthers our
nderstanding of the mechanisms of mortality and mor-
idity associated with chronic left ventricular dysfunction
as emerged (1–3). Subsequently, medical and device
herapies are now available that reduce symptoms, reverse
rogression of left ventricular dysfunction, and, impor-
antly, improve long-term survival without the need for
eart transplantation (1–10). Just 30 years ago, the hope
or survival in patients with heart failure (HF) was dismal
nd centered on transplantation as the ultimate therapy
11). Consequently, it is not surprising that most cardi-
logists with specific training in treating HF patients
ave had an emphasis on transplant-related medical care.
n fact, while specific training requirements and a certi-
cation process exist for transplant cardiology (12), there
re no published criteria describing acceptable training as
HF specialist. The realities of transplant organ avail-
bility, age at the time of transplant evaluation, and
omorbidities make heart transplantation an epidemio-
ogically insignificant intervention available to only a few
F patients. In fact, almost 80% of HF patients are over
he age of 65 years (13). Most patients with HF will never
e candidates for heart transplantation. The historic
oupling of specialized HF management training with
he limited opportunities one encounters in transplant
ardiology may have unwittingly slowed important
rowth in the numbers of HF specialists.
From the *Department of Medicine, Cardiovascular Diseases Section, Department
f Physiology, University of Oklahoma Health Sciences Center, Oklahoma City,
klahoma; and the †Department of Medicine, Division of Cardiovascular Medicine,
epartment of Physiology, The Ohio State University, Columbus, Ohio.
Manuscript received March 17, 2004; revised manuscript received April 16, 2004,mccepted April 27, 2004.Specialized training programs for HF management are
ncreasing because more complicated treatment modali-
ies are required, as well as available, to achieve favorable
linical outcomes without relying on protracted and
xpensive in-hospital management (13–16). Specialized
reatment centers that provide frequent follow-up and
rganized delivery of standard of care therapy, for exam-
le, have a dramatic impact on hospital use, re-
dmissions, and length of hospital stay (14 –16). Most
F specialty treatment centers create a multidisciplinary
eam of providers that includes cardiologists who have a
pecial interest or training in HF management and
on-physician providers who follow algorithms to fre-
uently evaluate patients and adjust their long-term
edical therapy. The success of specialized treatment
enters underscores the importance of applying standard
f care medical therapy and demonstrates that patients
ith HF indeed have hope for a reduction of symptoms
nd enhanced survival. It also demonstrates that manag-
ng a large number of HF patients can be quite labor
ntensive and complicated. This makes it more difficult to
chieve the results of specialty treatment centers in
eneral cardiology or internal medicine practice settings.
To further complicate HF management, recently a new
class” of therapy for HF patients has emerged. In
ddition to maximal medical care (i.e., drug therapy),
evices intended to prevent sudden cardiac death (im-
lantable cardioverter-defibrillators [10]) and cardiac re-
ynchronization devices (biventricular pacemakers [4 –9])
educe morbidity and mortality in appropriate patient
opulations. Devices under investigation for the treat-
ent of HF include percutaneously applied ventricular
ssist devices, ultrafiltration, implantable hemodynamic
onitoring systems, and others. For example, implanted
onitoring systems provide continuous cardiovascular
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o guide medical management and reduce episodes of
evere decompensation in high-risk patients (17–19). As
ur understanding of opportunities with this new thera-
eutic class develops, new applications of device therapy
n HF are emerging, creating substantially larger groups
f patients in whom device therapy is appropriate. Al-
hough this is exciting and provides hope for a further
eduction of HF morbidity and mortality, it may strain
he available workforce qualified to implant devices.
eneral cardiologists implant and follow most pacemak-
rs, whereas most of the implantations and virtually all of
he follow-up of implantable cardioverter-defibrillators
re the responsibility of electrophysiologists. Electro-
hysiologists or cardiologists with higher volume pace-
aker implant experience usually perform biventricular
acemaker system implantations aimed at cardiac resyn-
hronization therapy. The dramatic increase in the num-
er of implants, along with the expected epidemic of HF
atients in the next 30 years, makes it clear that there is
need for larger numbers of providers that are competent
n implanting the devices designed for patients with HF.
urthermore, currently an artificial and inefficient dis-
onnect exists between implanting physicians and HF
pecialists. Many times, implanting physicians do not
ave specialized training or interest in HF management,
nd HF physicians do not have specialized training in
mplant procedures or long-term device management.
oupling an understanding of device therapy, including
mplantation techniques for some, with competence in
F management and pathophysiology will serve to fur-
her advance this very important and growing part of
ardiovascular disease management.
Although non-cardiologist providers currently treat
ost HF patients, several studies demonstrate that spe-
ialist care is more likely to conform to consensus
tandards and produces better outcomes in HF (20 –22).
his suggests that current training programs for primary
are providers (internal medicine and family practice)
ay not be delivering an adequate understanding of
ife-saving medical based therapeutic interventions. De-
ice therapies are, then, another layer of complexity in
hich primary providers do not have expertise as a result
f their training programs. That is not to say that primary
are providers cannot learn the intricacies of chronic HF
anagement, but specific training programs will be
equired to establish clinical competency. In the growing
Abbreviations and Acronyms
HF  heart failure
NASPE/HRS  North American Society of Pacing and
Electrophysiology/Heart Rhythm Societypidemic of HF, having more providers who have spe- (ialty training will only help deliver standards of care that
ill meet patients’ needs in a cost-efficient manner.
This paper outlines a new curriculum, instituted at the
niversity of Oklahoma Health Sciences Center and in a
odified form at the Ohio State University, for training of
nterventional HF cardiologists and for training internists in
F management. The programs are designed to increase
pecially trained individuals with competency in the spec-
rum of complex HF management. We suggest that this
ilot curriculum may provide the basis for a successful
trategy to provide specially trained providers equipped to
anage the growing epidemic of patients with HF. In the
uture, evaluation methods such as certification of special
ompetency may be required to ensure that providers have
ppropriate training and clinical experience to treat this very
mportant disease process.
The curriculum suggested calls for cardiovascular dis-
ase fellows to complete two years of general cardiology
raining followed by two years of training in HF man-
gement (Table 1). The general cardiology training
ortion of the HF fellowship conforms to requirements
nunciated in accreditation and certification standards for
eneral cardiology (12). In the third year of fellowship,
F training will consist of dedicated management of HF,
ncluding administration and supervision of inpatient and
utpatient HF treatment programs. The fellow will gain
xpertise in advanced competency in echocardiography
23), as well as comprehensive medical management of
he disease. The second year of training will ensure
ompetency in device implantation and management.
he device curriculum requirements will comply with
uidelines outlined by the North American Society of
acing and Electrophysiology/Heart Rhythm Society
able 1. Summary of Recommended Goals of Two-Year
nterventional Heart Failure Fellowship Program Designed to
tart After the First Two Years of General Cardiology Training
Interventional Heart Failure Fellowship
Training Goals Reference(s)
wo years of general cardiology training in accordance
with COCATS requirements
12
dministration of a multidisciplinary heart failure
treatment program
14–16
Drug/device management
Outpatient follow-up and therapy
Efficient inpatient care
evel 2 echocardiography training 23
evel 2 device training 24
75 primary operator implants for implantable
electronic devices
100 follow-up visits for implantable electronic
devices
30 primary operators for implantable electronic
device revisions
ransplant management 12
esearch
OCATS  Core Cardiology Training Symposium.NASPE-HRS) (24), including any updated training
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equired to establish both cognitive and technical com-
etency to implant cardiac defibrillators, pacemakers, and
iventricular devices. Specific training in the future use of
ew devices, such as implantable hemodynamic monitor-
ng systems, will be provided by this curriculum.
General internal medicine-trained physicians will enter
he training program for one year, following internal med-
cine residency, and will gain competency in medical man-
gement of HF coupled with level 1 competency in echo-
ardiography (Table 2). Although exposure to device
herapy is included and important in the curriculum for
eneral internists, device implant training is not part of the
urriculum. Device management would remain the direct
esponsibility of those specialists trained comprehensively in
his area. On the other hand, especially in the non-
electrophysiologic” aspects of device therapy, such as tele-
etric monitoring functions, it will be important for the
pecially trained internists to have substantial training. The
oals will be to train a provider that can competently
aximize drug therapy to reduce the need for hospitaliza-
ions, while improving survival and quality of life.
We feel strongly that the interventional HF cardiologist
nd the HF internist will bolster the workforce available for
atients with chronic HF and, hopefully, will create a group
f specialists with specific clinical competency to comple-
ent those who traditionally have implanted and managed
evice therapy. The proposed fellowship programs would
rovide the interventional HF specialist with competency in
“niche” procedural skill without prolonging overall train-
ng time. This may make HF specialization training more
ttractive to applicants also considering interventional car-
iology or electrophysiology.
In the future, HF management will very likely involve
ore devices for therapy and monitoring. In that spirit, we
ubmit the suggested training goals for HF specialty fellow-
hip. If a thoughtful approach to meet the needs of the
pcoming HF epidemic is not entertained, our health care
able 2. Summary of Suggested Training Goals for Internal
edicine-Trained Physicians Eligible for ABIM Specialty
oard Examination
Internal Medicine Heart Failure
Fellowship Training Goals Reference(s)
BIM specialty board eligibility
dministration of a multidisciplinary heart
failure treatment program
14–16
Drug/device management
Outpatient follow-up and therapy
Efficient inpatient care
evel 1 echocardiography training 23
nderstand telemetry information available
from implanted electronic devices
24
nternal medicine aspects of transplantation 12
esearch
BIM  American Board of Internal Medicine.ystem is destined to provide substandard, cost-inefficientare, and many patients will continue to miss the benefit of
ife-saving interventions, including device management.
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